Lung Cancer Clinical Trial
Official title:
CT_ Guided Percutaneous Microwave Ablation in Treatment of Pulmonary Malignancies
Lung cancer remains to be an important global issue as it is the leading cause of cancer_ related mortality for both men and women worldwide .Since more than two thirds of cases are diagnosed at an advanced stage,the survival rate of lung cancer is one of the lowest among all cancers.
Currently , Surgery is one of the curative treatment option for primary lung cancer but most
patients are either diagnosed at an advanced stage or are unfit for surgery due to medical
co_morbidities or poor underlying lung reserve , less than a third of all lung cancer
patients can undergo surgical resection .
Lung metastasectomy is considered a therapeutic option increasing the survival rate for
patients of pulmonary metastases but only 25%_30% of patients benefits from lung
metastasectomy due to multiplicity of pulmonary nodules or medical co_ morbidities .
In spite of a significant improvement of lung cancer chemotherapy and radiotherapy in recent
years , the overall clinical outcome is less than satisfactory compared with that brought by
surgical resection .Thus , it is urgent to provide a method which is more effective than
chemotherapy and radiotherapy and nearly effective as the surgical treatment for the patients
who are not eligible for surgery.
Local thermal ablation therapy of the tumor is the focus of recent research in the past
decades .This method is to deliver specific energy into the tumor tissue under the guidance
of image technology , which make the local tissue quickly reach 60°C where an irreversible
coagulative necrosis happens leading to necrosis of tumor cells .
CT_guided Microwave ablation is a minimally invasive technique that may be an alternative
treatment option for management of lung cancer in patients who are not candidate for surgery
.This method not only kill the insitu lung cancer cells , but also protect lung cancer tissue
.It can produce large volumes of cellular necrosis with reduced procedure time , can use
multiple antennae and can be used in lesions with cystic component and/or in proximity to
vascular structures.
Thus, CT guided microwave ablation is a promising new technique that is convenient ,easy
,causing less trauma ,associated with no need for general anaesthesia , fast recovery and
less complications.
;
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT03918538 -
A Series of Study in Testing Efficacy of Pulmonary Rehabilitation Interventions in Lung Cancer Survivors
|
N/A | |
| Recruiting |
NCT05078918 -
Comprehensive Care Program for Their Return to Normal Life Among Lung Cancer Survivors
|
N/A | |
| Active, not recruiting |
NCT04548830 -
Safety of Lung Cryobiopsy in People With Cancer
|
Phase 2 | |
| Completed |
NCT04633850 -
Implementation of Adjuvants in Intercostal Nerve Blockades for Thoracoscopic Surgery in Pulmonary Cancer Patients
|
||
| Recruiting |
NCT06006390 -
CEA Targeting Chimeric Antigen Receptor T Lymphocytes (CAR-T) in the Treatment of CEA Positive Advanced Solid Tumors
|
Phase 1/Phase 2 | |
| Recruiting |
NCT06037954 -
A Study of Mental Health Care in People With Cancer
|
N/A | |
| Recruiting |
NCT05583916 -
Same Day Discharge for Video-Assisted Thoracoscopic Surgery (VATS) Lung Surgery
|
N/A | |
| Completed |
NCT00341939 -
Retrospective Analysis of a Drug-Metabolizing Genotype in Cancer Patients and Correlation With Pharmacokinetic and Pharmacodynamics Data
|
||
| Not yet recruiting |
NCT06376253 -
A Phase I Study of [177Lu]Lu-EVS459 in Patients With Ovarian and Lung Cancers
|
Phase 1 | |
| Recruiting |
NCT05898594 -
Lung Cancer Screening in High-risk Black Women
|
N/A | |
| Active, not recruiting |
NCT05060432 -
Study of EOS-448 With Standard of Care and/or Investigational Therapies in Participants With Advanced Solid Tumors
|
Phase 1/Phase 2 | |
| Active, not recruiting |
NCT03667716 -
COM701 (an Inhibitor of PVRIG) in Subjects With Advanced Solid Tumors.
|
Phase 1 | |
| Active, not recruiting |
NCT03575793 -
A Phase I/II Study of Nivolumab, Ipilimumab and Plinabulin in Patients With Recurrent Small Cell Lung Cancer
|
Phase 1/Phase 2 | |
| Terminated |
NCT01624090 -
Mithramycin for Lung, Esophagus, and Other Chest Cancers
|
Phase 2 | |
| Terminated |
NCT03275688 -
NanoSpectrometer Biomarker Discovery and Confirmation Study
|
||
| Not yet recruiting |
NCT04931420 -
Study Comparing Standard of Care Chemotherapy With/ Without Sequential Cytoreductive Surgery for Patients With Metastatic Foregut Cancer and Undetectable Circulating Tumor-Deoxyribose Nucleic Acid Levels
|
Phase 2 | |
| Recruiting |
NCT06010862 -
Clinical Study of CEA-targeted CAR-T Therapy for CEA-positive Advanced/Metastatic Malignant Solid Tumors
|
Phase 1 | |
| Recruiting |
NCT06052449 -
Assessing Social Determinants of Health to Increase Cancer Screening
|
N/A | |
| Not yet recruiting |
NCT06017271 -
Predictive Value of Epicardial Adipose Tissue for Pulmonary Embolism and Death in Patients With Lung Cancer
|
||
| Recruiting |
NCT05787522 -
Efficacy and Safety of AI-assisted Radiotherapy Contouring Software for Thoracic Organs at Risk
|